Increased oxidative damage and mitochondrial dysfunction have been suggeste
d to play crucial roles in the pathogenesis of several neurodegenerative di
seases, including Parkinson's disease and Alzheimer's disease. In this revi
ew, we will focus on progressive supranuclear palsy (PSP), a rare parkinson
ian disorder with tau pathology. Particular emphasis is placed on the genet
ic and biochemical data that has emerged, offering new perspectives into th
e pathogenesis of this devastating disease, especially the contributory rol
es of oxidative damage and mitochondrial dysfunction.